Background Endoscopic procedures using electrohydraulic lithotripsy (EHL) or intraductal laser lithotripsy (ILL) are the methods of choice for managing difficult common bile duct (CBD) stones. This retrospective study examined 10 years of Swedish experience using a motherbaby endoscopic system to assist in the fragmentation of CBD stones by EHL and ILL. Methods Between 1995 and 2006, 44 patients with a median age of 80 years underwent EHL or ILL at two Swedish centers after conventional endoscopic fragmentation of CBD stones had failed. Long-term follow-up assessment was conducted for 9 to 126 months (median, 53 months). Results Final stone clearance after EHL or ILL treatment with or without additional conventional endoscopic retrograde cholangiopancreatography (ERCP) was achieved for 34 (77%) of 44 patients. The results for 10 patients (23%) were defined as failures. Complete or partial stone fragmentation and definitive duct clearance were achieved in one session for 23 patients (52%). A second EHL or ILL attempt made in five cases of primary failure led to definitive stone clearance in three cases. Two patients experienced perioperative complications (stone basket impaction). Mild post-ERCP pancreatitis occurred for one patient and cholangitis for two patients. During long-term follow-up evaluation, recurrent CBD stones were found in one patient.
A number of studies from highly specialized centers with heavy caseloads bear witness to the safety and efficacy of both EHL and ILL [8-11, 14, 15] . The current study is the first Scandinavian report of mother-baby-scope-assisted lithotripsy with EHL, ILL, or both and includes information concerning long-term clinical outcome (stone recurrence and complications) for a patient population with a median age of 80 years at the time of treatment.
Materials and methods
The current study examined the success rate for motherbaby-scope-assisted lithotripsy from the two Swedish endoscopic centers (Ö stersunds County Hospital and Karolinska University Hospital, Huddinge) that routinely performed the procedure during the study period. Between December 1995 and September 2006, 49 treatment sessions were performed for 44 patients (22 women and 22 men) with a median age of 80 years (range, 42-92 years) who received EHL (n = 28) or ILL (n = 21). The median diameter of the CBD stones was 15 mm (range, 5-35 mm), with 72% of the stones having a diameter greater than 15 mm. A solitary CBD stone was found in 28 patients (64%). Four patients (9%) had more than five stones. The characteristics of the study patients are shown in Table 1 .
All peroral lithotripsy procedures were performed under direct optic visualization by two endoscopists using an Olympus CHFB 30 (Olympus Optical, Tokyo, Japan) (baby scope) that had an outer diameter of 3.4 mm and an inner channel diameter of 1.2 mm, in conjunction with an Olympus TJF, TJF 160R, or TJF 160VR (Olympus Optical, Tokyo, Japan) (mother scope) that had a working channel of 4.2 mm. Electrohydraulic lithotripsy was performed using a 1.9-Fr coaxial electrode probe (Olympus Lithotron EL-25, 1,000 mJ; Olympus Inc., Stockholm, Sweden). Pulsed dye laser lithotripsy was performed using a Candela Lasertriptor MDL 2000 (Candela, Boston, MA) at a wavelength of 504 nm and a fine-caliber laser fiber with a diameter of 200 lm. All procedures were performed with the patient under general anesthesia. The median duration of the procedures was 120 min (range, 25-210 min).
At the time that bile duct obstruction due to CBD stone was diagnosed, 39 patients (87%) were experiencing jaundice. Before endoscopic treatment, 75% of the patients reported upper abdominal pain, and 20% had recurrent symptoms of cholangitis. At the time of mother-baby-scopeassisted lithotripsy, all the patients had undergone at least two (range, 2-10) conventional endoscopic retrograde cholangiopancreatography (ERCP) sessions and had some type of biliary drainage in place including endoscopic stent (n = 40), percutaneous transhepatic cholangiography drainage (n = 2), or nasobiliary tube (n = 1). All but one of the patients had undergone a sphincterotomy before the mother-baby endoscopic procedure. Mechanical stone extraction had been unsuccessful for these patients because the stone was too large (n = 30), too hard (n = 7), or impacted (n = 7). Before the EHL or ILL procedure, 18 patients (41%) had undergone a cholecystectomy.
Information and data concerning late biliary-related problems were collected from pertinent medical charts or by contacting the patients still living at the time of the follow-up evaluation. The study protocol was approved by the regional ethical committee (Regionala Etikprövnings Nämnden).
Results

Stone clearance rate
At the end of the treatment period, 34 (77%) of the 44 patients were stone free (Fig. 1 ). In the subgroup of patients 80 years of age or older, 86% were stone free at the end of the treatment period. Total clearance of CBD stones after complete or partial fragmentation was achieved within a single session for 23 patients (52%). For 12 other 12 (27) C15\25 mm: n (%) 24 (55)
Stone location
Choledochal duct 37
Common hepatic duct 4 Cystic duct (Mirizzi) 3
No. of stones: n (%)
ASA American Society of Anesthesiology patients (27%), an additional ERCP was performed. Bile duct stone extraction was completed successfully for 10 of the 12 patients by using a basket or balloon catheter alone (4 patients) or in combination with mechanical lithotripsy (6 patients). The two failures in the additional ERCP group involved patients with partial fragmentation who underwent unsuccessful mechanical lithotripsy. Five patients required an additional EHL or ILL session. Fragmentation and stone clearance was finally achieved for three of these five patients. The remaining two patients had a residual stone after the procedure. Altogether, endoscopic stone clearance failed for 10 (23%) of the patients (Table 2) . Of these 10 patients, 2 were treated using ESWL without success. Surgery was performed in six cases (14%). The reasons for surgery were basket impaction (n = 2), Mirizzi syndrome (n = 3), and a referral hospital's preference for surgery rather than a second EHL attempt (n = 1). The remaining four patients were not suitable candidates for surgery and were treated with permanent endoprostheses.
Postprocedural complications
One patient died of a myocardial infarction at home 10 days after a successful ILL with complete duct clearance. The cause of death was considered unrelated to the endoscopic procedure. Transient post-ERCP complications occurred for four of the patients (9%). The incidence and types of early complications are given in Table 3 . A single case of mild post-ERCP pancreatitis was observed within the first 24 h after the procedure. Two patients had brief episodes of cholangitis that responded well to antibiotics.
Long-term follow-up evaluation
The remaining 43 patients after death of 1 patient were followed up for a median of 53 months (range, 9-126 months). Of these 43 patients, 13 had died by the end of the study period. The median age at death was 84 years (range, 57-91 years), which occurred a median of 50 months (range, 12-88 months) after the first EHL or ILL procedure. The causes of death were cardiovascular disease (n = 4), renal failure (n = 2), hepatocellular carcinoma (n = 1), traumatic intracranial bleeding (n = 1), and an unspecified cause (n = 5). At completion of the study, the median age of the 30 patients still living was 83 years (range, 43-95 years). Of the 43 patients, 6 (14%) experienced a late biliary symptom or complication (Table 4) . All these problems occurred within the first 2 years after the first EHL or ILL procedure. Three of the six patients had been readmitted due to suspicion of CBD stone recurrence, but a demonstrable CBD stone was found in only one of the three patients. The remaining two patients recovered spontaneously. Two other patients experienced single episodes of acute cholangitis, which responded well to antibiotics. In addition, one patient underwent cholecystectomy due to acute cholecystitis and was found to have a normal perioperative cholangiogram.
Our data from both the living and deceased patients gave no indication of CBD strictures developed after EHL or ILL treatment. The 21 patients in the long-term study who were 80 years of age or older at the time of successful duct clearance lived stone free for an average of 45 months (median, 44 months; range, 12-96 months) until their deaths or the end of the study period.
Discussion
The current study, which includes virtually all cases of mother-baby-scope-assisted lithotripsy performed in Sweden between 1995 and 2006, shows that EHL and ILL are effective, safe treatment options for endoscopic removal of difficult CBD stones refractory to more conventional endoscopic methods. Clear visualization of the stone and close contact with the EHL or ILL probe is a prerequisite for successful fragmentation and subsequent duct clearance. Clear visualization is likewise important for avoidance of perforation injuries [8, 16] . We observed no duct injuries related to EHL or ILL lithotripsy.
General anesthesia was used because the procedures are lengthy and complex. Large concretions (20 mm in diameter) are undoubtedly more difficult to handle and were the major factor accounting for failure. In the current series, 8 of the 10 treatment failures occurred with stones in that size range, although complete stone removal was obtained for 12 (60%) of 20 patients with stones that size. In contrast, neither the number of stones nor their location influenced our success rate. Another important factor was the presence or absence of a superimposed complicating factor (e.g., Mirizzi syndrome, a cancer stricture, or a technical failure) ( Table 2) .
The current study had the oldest patient group (median age, 80 years; mean age, 74 years) compared with several other trials evaluating MB-assisted EHL or ILL, namely, Arya et al. [10] (mean age, 67.1 years), Adamek et al. [11] (mean age, 70 years), Neuhaus et al. [8] (mean age, 71 years), Jakobs et al. [14] (median age, 65.8 years), and Hui et al. [17] (median age, 74 years). In addition, according to the five-grade classification system of the American Society of Anesthesiologists (ASA), nearly half of our patients (43%) had poor physical status (ASA grade 3 or worse). The health of six patients was considered too poor due to concomitant diseases for them to undergo general surgery.
Nevertheless, complete stone clearance was achieved for 77% of all the patients, including the octogenarians and the frail patients deemed unable to tolerate open surgery. This success rate is within the range of previously reported rates (74-90%) [9, 10] . If EHL or ILL had not been used, permanent stent placement probably would have been the only other treatment option for these patients. Indeed, several patients in the group had already had stents for lengthy periods and had required repeated admissions to the health care system due to stent dysfunction and relapses of cholangitis. Results from other studies have shown that permanent stent placement among the elderly is more hazardous than EHL and carries an increased risk of both cholangitis and mortality [17] [18] [19] .
In the current study, few complications occurred during the follow-up period (median, 53 months), and these complications occurred only within the first 2 years after the EHL or ILL treatment. Besides the two patients who experienced attacks of cholangitis, three patients (7%) presented with abdominal pain suggestive of recurrent choledocholithiasis. Only one of these five patients had a demonstrable CBD stone (*5 mm), and it was easily extracted using conventional ERCP. However, we cannot rule out the possibility that CBD stones passed spontaneously before the ERCP investigations.
According to several other studies, stone recurrence rates after endoscopic transpapillary stone extraction procedures vary from 3.2% to 19% [14, [20] [21] [22] [23] . On the other hand, as Tanaka et al. [24] suggested in a prospective study, the real recurrence rate may be difficult to determine because the possibility always exists that some stone recurrences may not be not accompanied by clinical symptoms.
In a recent metaanalysis, McAlister et al. [25] reviewed five randomized clinical trials and stated that prophylactic cholecystectomy should be offered to all patients considered fit for surgery whose gallbladders remained in situ after endoscopic sphincterotomy and CBD clearance. The authors suggested that prophylactic cholecystectomy after clearance of choledocholithiasis should be studied by a randomized clinical trial involving patients considered high risk for surgery [25] . However, the presence or absence of the gallbladder did not seem to influence the long-term outcome of symptomatic stone recurrence in the current series. Although a cholecystectomy had been performed for only 18 (41%) of our patients, stone recurrence was demonstrated in only one patient (2%). That individual had not undergone a cholecystectomy. In a group of 71 patients, 59.2% of whom had undergone cholecystectomy, Jakobs et al. [14] reported a symptomatic stone recurrence rate of 15.5% after successful laser lithotripsy. The use of ESWL is another third-line treatment option for difficult CBD stones [11] [12] [13] 15] . We tried ESWL in two cases after unsuccessful EHL, but it was unsuccessful in both cases. In a prospective randomized trial comparing ILL with ESWL, Neuhaus et al. [8] found both methods to be safe and effective, but ILL was significantly more effective in terms of bile duct clearance, the number and duration of treatment sessions, and the number of complications.
In conclusion, the current study confirms that peroral endoscopic EHL and ILL are effective methods for fragmentation of difficult CBD stones. It also shows that frail and elderly patients can become stone free and live many years without experiencing late biliary complications. The advent of the single-operator peroral cholangioscope since the study period [26] [27] [28] may further improve the treatment outcome for high-risk elderly patients.
